Brief: Unichem Laboratories To Consider Consolidation Of Generics Formulations Business In US Market
23/09/2024 06:40
Sept 23 (Reuters) - Unichem Laboratories Ltd UNLB.NS :
* UNICHEM LABORATORIES - TO CONSIDER CONSOLIDATION OF
GENERICS
FORMULATIONS BUSINESS IN US MARKET
Source text for Eikon: ID:nBSE9Qs9KG
Further company coverage: UNLB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Unichem Laboratories
See all newsIndia's Unichem Laboratories drops after US FDA inspection ends with five observations
India's Unichem Labs falls after appeal against tax demand rejected
Brief: Unichem Laboratories June-Quarter Consol PAT 414.7 Million Rupees
India's Unichem Laboratories jumps on posting Q1 profit
India's Unichem Laboratories surges in busiest session ever after block deal at premium